about
Evaluating the Use of a Negative D-Dimer and Modified Low Wells Score in Excluding above Knee Deep Venous Thrombosis in an Outpatient Population, Assessing Need for Diagnostic Ultrasound.Activated Protein C Drives the Hyperfibrinolysis of Acute Traumatic Coagulopathy.The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.A paired comparison of thawed and liquid plasma.A computer-based model to assess costs associated with the use of factor VIII and factor IX one-stage and chromogenic activity assays.Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents.Pre-analytical heat treatment and a FVIII ELISA improve Factor VIII antibody detection in acquired haemophilia A.Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experience.Wilate use in 47 children with von Willebrand disease: the North London paediatric haemophilia network experience.Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.The Future of Activated Clotting Time?A multicenter study to evaluate automated platelet aggregometry on Sysmex CS-series coagulation analyzers-preliminary findingsAn unusual cause of bleeding in an elderly patientAnti-Xa activity supports using a simple dosing algorithm for tinzaparin for anticoagulation in hemodialysisOptimization of pre-analytical heat treatment for inhibitor detection in haemophilia AThawing times and hemostatic assessment of fresh frozen plasma thawed at 37°C and 45°C using water-bath methodsLaboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guidelineLaboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guidelineA novel variant causing α2 antiplasmin deficiency: case report and experience in a UK centreInfluence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixabanLupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
P50
Q33711012-96A968F3-EA74-4330-968D-AB7699A489CAQ37600822-91D04097-F6C3-4CC1-B45F-DBA2FBF09891Q39136839-06AB3C91-373A-4869-807F-FE70DBCFA884Q39139878-5C022BAB-242F-48E7-B315-082CAE5A6243Q45004372-DE038CFA-A296-4D7F-98B3-91441D71D498Q45856076-93E03599-ACED-4C67-8C6D-3A2A0D324EE6Q45864972-CFC29C68-4A07-4D40-9279-A61DB2586A6AQ45867482-1167B04A-FB80-41AF-864D-D228242232C0Q45867552-4961B1B3-DA40-4BFF-8366-B90DBEB4534EQ53174605-F2BC70AD-C009-4A8D-88FE-B343A0FA72E4Q57171430-0D3395E3-B6B5-43C6-91AA-20B139560CD3Q57823474-1CAE94EE-3D28-4303-B93D-A1C2E7EECB33Q84892317-D3D1C052-27C7-4386-9821-064FE46B059AQ86927386-957CFA83-9829-4229-BB65-6C54F368D96EQ88734212-72ABA7C6-AF53-4F6D-B41E-D7B341BF3606Q90746859-C33AB5A4-AC72-4A88-AA73-0C09804E17F1Q92041367-E325A49F-E6D8-49E4-9583-06ECA0D1C174Q92143697-A3D78F09-EDE4-4B40-9FF7-FFA2CFD25DCCQ92806088-1336C8F1-7AB1-4748-88ED-816AD35332C0Q93368371-570CE4CA-788E-473C-AE8F-0EE8F1E51FE3Q94531526-BE21BCDB-BDBA-41D2-A887-BB0B31FEFCFE
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sean Platton
@en
Sean Platton
@nl
type
label
Sean Platton
@en
Sean Platton
@nl
prefLabel
Sean Platton
@en
Sean Platton
@nl
P31
P496
0000-0002-5466-0448